EU approves Scanis mammography system
Software designed to automatically locate and highlight subtle abnormalities is part of a computer-aided mammography system that recently gained European marketing approval.The Mammex TR is a computer-aided diagnosis system intended to help
Software designed to automatically locate and highlight subtle abnormalities is part of a computer-aided mammography system that recently gained European marketing approval.
The Mammex TR is a computer-aided diagnosis system intended to help radiologists improve their accuracy in evaluating mammograms. The Foster City, CA, company did much of the early development and testing of the technology with the University of California, San Francisco, and Stanford University.
According to Scanis, proprietary rule-based algorithms and filters identify and classify small and obscure features of diagnostic interest. In other words, the software is designed to find subtle abnormalities the radiologist may have missed. It works by digitizing film mammograms and displaying them on a monitor so the radiologist can compare them to the original.
Now that the Mammex TR has obtained the CE Mark under the European Union's Medical Device Directive, Scanis will be starting the FDA premarket approval process in the next few months, according to company spokesperson Bob Chapman. A Canadian application is expected to be approved shortly, he said.
"We have a close relationship with the University of Southern California, which is developing a protocol," Chapman said. "and we will be working with several more institutions."
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
